News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
Federal health officials have changed the game for COVID vaccine access. Pregnant moms and others who rely on them to protect a high-risk family member are scared.
The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes ...
FDA leaders said on May 20 that clinical ... by Novavax Inc. Vaccine manufacturers have said that because COVID vaccines change annually to target specific strains of the virus, the proposed ...
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
The FDA is proposing to limit annual COVID-19 ... by Novavax Inc. Vaccine manufacturers have said that because COVID vaccines change annually to target specific strains of the virus, the ...
Dr. Marty Makary, the Johns Hopkins surgeon and professor who Trump tapped to lead the FDA, clarified the recently changed ...
The US Centers for Disease Control and Prevention has updated its immunization schedule for children, days after US Health ...
Kennedy announced that the CDC is no longer recommending routine COVID-19 vaccinations for pregnant women and healthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback